A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy
Conditions
- Wet Age-related Macular Degeneration
Interventions
- DEVICE: NeoVista Ophthalmic System
Sponsor
NeoVista